Guardant health announces inducement grants under nasdaq listing rule 5635(c)(4)

Palo alto, calif.--(business wire)--guardant health, inc. (nasdaq: gh), a leading precision oncology company, today announced that on february 11, 2025, the compensation committee of guardant's board of directors approved the granting of restricted stock units (“rsus”) representing 110,681 shares of its common stock to 102 new non-executive employees and one non-qualified stock option award to purchase 22,091 shares of its common stock to one new non-executive employee with a grant date of febr.
NDAQ Ratings Summary
NDAQ Quant Ranking